This site is archived and is no longer updated. It will be taken offline in mid-July. All the latest AWMSG recommendations, guidance and information is available on our new website at: https://awmsg.nhs.wales/.
awmsg logo



ketorolac/phenylephrine (Omidria®)


Reference No. 1194

Publication date:
27/07/2016


Appraisal information

ketorolac/phenylephrine (Omidria®) 12.37mg/ml/4.24mg/ml intraocular


Company: Omeros Corp
BNF category: Eye
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 26/07/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

This product is currently not marketed in the UK. In the absence of a submission from the holder of the marketing authorisation, ketorolac/phenylephrine (Omidria®) cannot be endorsed for use within NHS Wales for the maintenance of intraoperative mydriasis, prevention of intraoperative miosis and reduction of acute postoperative ocular pain in intraocular lens replacement surgery.
Statement of Advice (SOA)
Download